CUA Educational Content

Collaborative Practice in Prostate Cancer: How is this actually done?

Session #3 of the Prostate Cancer and Cardiovascular Disease program series
In partnership with IC-OS and EAU



  • CV decision-making in advanced PC
  • Discuss factors that influence recommendations for CABG, valve surgery, transcatheter valve intervention in patients with metastatic PC
  • Optimal cardioprotective therapy for high-risk patients
  • Should ADT or androgen receptor blockers be withheld (if ever)?
  • Acute MI, HTN out of control, etc.
  • Any CV conditions that preclude this treatment
  • Considerations of complex decisions around antithrombotic therapies




This program has received financial support from Ferring in the form of an educational grant.